Oncology Institute Inc
NASDAQ:TOI

Watchlist Manager
Oncology Institute Inc Logo
Oncology Institute Inc
NASDAQ:TOI
Watchlist
Price: 3.38 USD 6.29%
Market Cap: 332.5m USD

Oncology Institute Inc
Other Long-Term Assets

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

Oncology Institute Inc
Other Long-Term Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Long-Term Assets CAGR 3Y CAGR 5Y CAGR 10Y
Oncology Institute Inc
NASDAQ:TOI
Other Long-Term Assets
$589k
CAGR 3-Years
25%
CAGR 5-Years
43%
CAGR 10-Years
N/A
Universal Health Services Inc
NYSE:UHS
Other Long-Term Assets
$741.1m
CAGR 3-Years
4%
CAGR 5-Years
5%
CAGR 10-Years
8%
Encompass Health Corp
NYSE:EHC
Other Long-Term Assets
$151.7m
CAGR 3-Years
-10%
CAGR 5-Years
-13%
CAGR 10-Years
-6%
Tenet Healthcare Corp
NYSE:THC
Other Long-Term Assets
$72m
CAGR 3-Years
9%
CAGR 5-Years
-30%
CAGR 10-Years
-14%
HCA Healthcare Inc
NYSE:HCA
Other Long-Term Assets
$277m
CAGR 3-Years
-16%
CAGR 5-Years
-13%
CAGR 10-Years
-10%
Ensign Group Inc
NASDAQ:ENSG
Other Long-Term Assets
$99.9m
CAGR 3-Years
0%
CAGR 5-Years
23%
CAGR 10-Years
17%
No Stocks Found

Oncology Institute Inc
Glance View

Market Cap
329.8m USD
Industry
Health Care

The Oncology Institute, Inc. provides cancer care treatment services. The company is headquartered in Cerritos, California. The company went IPO on 2020-03-13. The firm manages community-based oncology practices that serve patients at approximately 55 clinic locations across eight markets and four states throughout the United States. The Company’s managed clinics provide a range of medical oncology services, including physician services, in-house infusion and dispensary, clinical trial services, programs like outpatient stem cell transplants and transfusions, along with 24/7 patient support. Through the Innovative Clinical Research Institute (ICRI), the Company also provides and manages clinical trial services and research for the benefit of cancer patients. Its services, such as managing clinical trials, palliative care programs and stem cell transplants, are accessed through academic and tertiary care settings. Its managed clinics primarily serve adult and senior cancer patients in markets that have Medicare Advantage (MA) plans.

TOI Intrinsic Value
2.53 USD
Overvaluation 25%
Intrinsic Value
Price

See Also

What is Oncology Institute Inc's Other Long-Term Assets?
Other Long-Term Assets
589k USD

Based on the financial report for Dec 31, 2024, Oncology Institute Inc's Other Long-Term Assets amounts to 589k USD.

What is Oncology Institute Inc's Other Long-Term Assets growth rate?
Other Long-Term Assets CAGR 5Y
43%

Over the last year, the Other Long-Term Assets growth was 5%. The average annual Other Long-Term Assets growth rates for Oncology Institute Inc have been 25% over the past three years , 43% over the past five years .

Back to Top